PRAVASTATIN SODIUM
- Product NDC
- 50090-7709
- 11-digit product format
- 500907709
- Labeler code
- 50090
- Product ID
- 50090-7709_f0d2cf93-5c22-4df7-b66a-0b90ce2a614b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- PRAVASTATIN SODIUM
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA077987
- Marketing category
- ANDA
- Marketing start
- 2024-06-01
- Substance
- PRAVASTATIN SODIUM
- Active strength
- 20 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- PRAVASTATIN SODIUM
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PRAVASTATIN SODIUM | 20 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 3M8608UQ61 |
| Rxcui | 904467 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-7709-0 | PRAVASTATIN SODIUM | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
| 50090-7709-1 | PRAVASTATIN SODIUM | 90 in 1 BOTTLE | TABLET | 90 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-7709-0 | 50090770900 | 30 TABLET in 1 BOTTLE (50090-7709-0) | 30 tablet | 2025-10-14 | No | No | Current |
| 50090-7709-1 | 50090770901 | 90 TABLET in 1 BOTTLE (50090-7709-1) | 90 tablet | 2025-10-14 | No | No | Current |